Leerink Partnrs Has Bearish Forecast for ACHC Q1 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Stock analysts at Leerink Partnrs cut their Q1 2025 EPS estimates for Acadia Healthcare in a report released on Thursday, December 12th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.72 for the quarter, down from their previous estimate of $0.76. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q2 2025 earnings at $0.87 EPS, Q3 2025 earnings at $0.87 EPS, Q4 2025 earnings at $0.80 EPS, FY2025 earnings at $3.26 EPS and FY2026 earnings at $3.95 EPS.

A number of other equities research analysts have also recently commented on the stock. Barclays decreased their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. Royal Bank of Canada lowered their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research note on Monday, November 18th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. Finally, Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $75.44.

Acadia Healthcare Stock Down 0.4 %

ACHC stock opened at $40.48 on Monday. The business’s 50-day moving average price is $45.10 and its 200-day moving average price is $61.60. The stock has a market cap of $3.76 billion, a P/E ratio of 13.27, a PEG ratio of 1.77 and a beta of 1.29. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period last year, the firm earned $0.91 EPS. Acadia Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year.

Institutional Trading of Acadia Healthcare

A number of large investors have recently added to or reduced their stakes in ACHC. GAMMA Investing LLC grew its holdings in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares in the last quarter. Blue Trust Inc. grew its stake in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after buying an additional 248 shares in the last quarter. Commonwealth Equity Services LLC increased its holdings in shares of Acadia Healthcare by 3.5% in the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after buying an additional 257 shares during the last quarter. Atria Investments Inc raised its position in shares of Acadia Healthcare by 4.7% during the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares in the last quarter. Finally, KBC Group NV lifted its holdings in shares of Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after acquiring an additional 338 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.